Senores Pharmaceuticals Ltd.

₹791.1

0 (0%)

SENORES Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,658 Cr

P/E Ratio62.21

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	811.47	Bearish
10-DMA	805.4	Bearish
20-DMA	819.77	Bearish
50-DMA	805.62	Bearish
100-DMA	769.5	Bullish
200-DMA	674.87	Bullish

Historical Performance

1 Year

57.5%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	3,982	2,145	353	142
Total Expenditure	3,086	1,729	227	122
Other Income	193	28	37	5
Operating Profit	1,090	444	164	24
Interest	215	94	21	6
Depreciation	168	100	18	7
Profit Before Tax	706	249	124	11
Consolidated Net Profit	586	315	84	10
Adjusted EPS	13	10	9	1

Compounded Sales Growth

10 Years:94.9

5 Years:94.9

3 Years:94.9

TTM:13.2

Compounded Profit Growth

10 Years:126.1

5 Years:126.1

3 Years:126.1

TTM:13.2

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:54.1

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:8.6

last year:12.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	460	305	98	87
Total Reserves	7,401	1,738	357	278
Long-Term Borrowings	---	---	---	---
Total Non-Current Liabilities	1,552	1,277	337	122
Other Current Liabilities	1,267	936	285	6
Short Term Borrowings	312	324	82	20
Total Liabilities	12,082	6,069	1,311	587
Capital Work in Progress	442	178	81	3
Long Term Loans & Advances	87	40	12	11
Currents Investments	---	---	---	---
Short Term Loans and Advances	1,491	854	248	12
Total Current Assets	7,224	2,509	513	271
Total Assets	12,082	6,069	1,311	587
Adjusted Book Value	171	67	46	42

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 62.21, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 42.0%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹1090 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹3982 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1540903.8

No. of Shares: 1948 (Approx)

Performance:54.1%

P/L: ₹540903.8

NIFTY Performance: 9.4%

1 day Top Gainers